Four-year follow-up from the ENCORE trial: A randomized, controlled, non-inferiority study comparing eliglustat to imiglucerase in patients with Gaucher disease type 1 stabilized on enzyme replacement therapy (2016)

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ymgme.2015.12.229

Publication URI: http://dx.doi.org/10.1016/j.ymgme.2015.12.229

Type: Journal Article/Review

Parent Publication: Molecular Genetics and Metabolism

Issue: 2